PASSIVE IMMUNISATION OF CHILDREN WITH BOVINE COLOSTRUM CONTAINING ANTIBODIES TO HUMAN ROTAVIRUS
References (23)
- et al.
Reovirus-like agent as a cause of nosocomial diarrhea in infants
J Pediatr
(1977) - et al.
A randomised trial of oral gammaglobulin m low-birth-weight infants infected with rotavirus
Lancet
(1982) The randomisation and stratification of patients to clinical trials
J Chron Dis
(1974)- et al.
Rotavirus: the major etiologic agent of severe infantile diarrhea may be controllable by a "Jennerian" approach to vaccination
J Infect Dis
(1986) - et al.
Diarrhoea and rotavirus infection associated with differing regimens for postnatal care of newborn babies
J Clin Microbiol
(1979) - et al.
Risk factors associated with nosocomial rotavirus infection
Am J Dis Child
(1985) - M. Ringenbergs, Gp Davidson, J. Spence, S. Morris, Prospective study of nosocomial rotavirus infection in a paediatric...
Epidemiology of rotavirus infection in adults
Rev Infect Dis
(1987)- et al.
Spread of rotavirus within families, a community based study
Br Med J
(1983) - et al.
Human rotavirus in lambs: infection and passive protection
Infect Immun
(1977)
Immunity to neonatal calf diarrhea virus
J Am Vet Med Assoc
Cited by (155)
Evaluating the effectiveness of colostrum as a therapy for diarrhea in preweaned calves
2022, Journal of Dairy ScienceCitation Excerpt :Bovine colostrum has been evaluated as a therapeutic for diarrhea in several studies across many different species. It has been determined that the severity and duration of acute diarrhea in children can be reduced with colostrum therapy (Davidson et al., 1989; Rathe et al., 2014; Barakat et al., 2020). Similarly, bovine colostrum has been found to reduce diarrhea incidence and the growth of diarrhea causing pathogens in piglets (Sugiharto et al., 2015).
Fermented, ultrasonicated, and dehydrated bovine colostrum: Changes in antimicrobial properties and immunoglobulin content
2020, Journal of Dairy ScienceCitation Excerpt :It is known that the immunoglobulins found in BC bind to many human pathogens and allergens and can neutralize infection of human cells, as well as treat gastrointestinal inflammation (Ulfman et al., 2018). Also, passive oral administration of BC has been experimentally evaluated as a preventive or therapeutic modality for a variety of enteric infections (Tacket et al., 1988; Davidson et al., 1989; Tacket et al., 1992; Greenberg and Cello, 1996; Freedman et al., 1998; Savarino et al., 2017). Food formulations with BC can compensate or have a beneficial effect on health due to the addition of specific components if those components are lacking in the daily diet (Santini and Novellino, 2018).
Engineering of milk-based beverages: Current status, developments, and consumer trends
2019, Milk-Based Beverages: Volume 9: The Science of BeveragesIsolation of biofunctional bovine immunoglobulin G from milk- and colostral whey with mixed-mode chromatography at lab and pilot scale
2018, Journal of Chromatography ACitation Excerpt :Isolated IgG may be used to specifically target pathogenic bacteria in bacterial skin infections without affecting the healthy microflora and causing the development of therapy resistance. The specific titer of immunoglobulins in colostrum against a certain pathogen such as Staphylococcus aureus can be increased by immunizing the cow as described for other pathogens such as enterotoxigenic Escherichia coli [6,7], Clostridium difficile [8,9], Shigella flexneri [10] or rotavirus [11]. Prerequisite of a development of IgG isolated from colostrum as drug substance for therapeutic use, is the standardized production of pure and active IgG at an industrial scale.
Passive Immunization
2017, Plotkin's Vaccines